Search
Menu
PI Physik Instrumente - Microscope Stages LB ROS 11/24

Imaging Diagnostic Signs Agreement With Schering

Facebook X LinkedIn Email
FORT LAUDERDALE, Fla., March 28 -- Imaging Diagnostic Systems Inc. announced it has signed a collaboration agreement with Schering AG, Germany, to evaluate the advantages of new fluorescence dyes developed by Schering for their potential to detect breast cancer.

Imaging Diagnostics' CTLM system will be used in conjunction with Schering AG's dyes during clinical trials. The collaboration will assist in determining the potential benefits of using both technologies to enhance the CTLM system's capability to detect breast cancer.

Excelitas Technologies Corp. - X-Cite Vitae  MR 11/24

Published: March 2002
News & Features

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.